Atlas Trials

Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2

Clinical trial NCT04081220 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04081220
Sponsor
The University of Texas Health Science Center at San Antonio
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Thrombocythemia, Essential
Start date
2020-04-09
Primary completion
2023-12-20
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.